Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain).
Parada Vázquez P, Pérez-Cachafeiro S, Castiñeira Domínguez B, González-Pérez JM, Mera Calviño JM, Souto-Rodríguez R, Falagán Cachafeiro Y, Pérez-Medrano I, Vázquez-Temprano N, Trigo M, Carrodeguas A, González-Sánchez JL, Durán-Parrondo C, Turnes J. Parada Vázquez P, et al. Among authors: perez medrano i. Gastroenterol Hepatol. 2024 Jun 29:502226. doi: 10.1016/j.gastrohep.2024.502226. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38950646 Free article. English, Spanish.
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.
Riveiro-Barciela M, Barreira-Díaz A, Esteban P, Rota R, Álvarez-Navascúes C, Pérez-Medrano I, Mateos B, Gómez E, De-la-Cruz G, Ferre-Aracil C, Horta D, Díaz-González Á, Ampuero J, Díaz-Fontenla F, Salcedo M, Ruiz-Cobo JC, Londoño MC. Riveiro-Barciela M, et al. Among authors: perez medrano i. Liver Int. 2024 Sep;44(9):2303-2314. doi: 10.1111/liv.15970. Epub 2024 May 29. Liver Int. 2024. PMID: 38809086
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Ampuero J, Lucena A, Berenguer M, Hernández-Guerra M, Molina E, Gómez-Camarero J, Valdivia C, Gómez E, Casado M, Álvarez-Navascuez C, Jorquera F, García-Buey L, Díaz-González Á, Morillas R, García-Retortillo M, Sousa JM, Pérez-Medrano I, Simón MÁ, Martínez J, Arenas J, Londoño MC, Olveira A, Fernández-Rodríguez C; ColHai Registry. Ampuero J, et al. Among authors: perez medrano i. Hepatology. 2024 Oct 1;80(4):791-806. doi: 10.1097/HEP.0000000000000826. Epub 2024 Mar 6. Hepatology. 2024. PMID: 38447019
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study.
Barreira-Díaz A, Riveiro-Barciela M, Fernández-Bonilla EM, Bernal V, Castiella A, Casado-Martín M, Delgado C, Londoño MC, Díaz-González Á, Pérez-Medrano I, Conthe A, Sala M, Mateos B, Gómez-Camarero J, Antón-Conejero D, Pozo-Calzada CD, Cuenca F, Villagrasa-Vilella A, Salcedo M. Barreira-Díaz A, et al. Among authors: perez medrano i. Ann Hepatol. 2024 May-Jun;29(3):101489. doi: 10.1016/j.aohep.2024.101489. Epub 2024 Feb 23. Ann Hepatol. 2024. PMID: 38403068 Free article.
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Among authors: perez medrano i. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Reig A, Álvarez-Navascués C, Vergara M, Gómez-Domínguez E, Gallego-Moya A, Pérez-Medrano IM, Fábrega E, Hernández-Guerra M, Berenguer M, Estevez P, Arencibia A, Morillas RM, Horta D, Albillos A, Casado M, De la Cruz G, Fernandez-Bonilla E, Molina E, Hijona L, Diago M, Fernández-Rodriguez CM, González-Santiago JM, Sala M, Gómez-Camarero J, Romero-Gomez M, Suárez F, Vargas V, Ferre-Aracil C, Andrade RJ, Chahri N, Parés A. Reig A, et al. Among authors: perez medrano im. Am J Gastroenterol. 2021 Nov 1;116(11):2250-2257. doi: 10.14309/ajg.0000000000001343. Am J Gastroenterol. 2021. PMID: 34158466
Post-colonoscopy colorectal cancer: Characteristics and predictive factors.
Muñoz García-Borruel M, Hervás Molina AJ, Rodríguez Perálvarez ML, Moreno Rincón E, Pérez Medrano I, Serrano Ruiz FJ, Casáis Juanena LL, Pleguezuelo Navarro M, Naranjo Rodríguez A, Villar Pastor C. Muñoz García-Borruel M, et al. Among authors: perez medrano i. Med Clin (Barc). 2018 Jan 12;150(1):1-7. doi: 10.1016/j.medcli.2017.04.015. Epub 2017 Jun 10. Med Clin (Barc). 2018. PMID: 28606560 English, Spanish.
Everolimus is safe within the first month after liver transplantation.
Rodríguez-Perálvarez M, Pérez-Medrano I, Guerrero-Misas M, González V, Poyato A, Barrera P, Ferrín G, Pozo JC, Sánchez-Frías M, Ciria R, Briceño J, Montero JL, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: perez medrano i. Transpl Immunol. 2015 Oct;33(2):146-51. doi: 10.1016/j.trim.2015.09.002. Epub 2015 Sep 24. Transpl Immunol. 2015. PMID: 26392195